| 3′UTR | 3′ untranslated region |
| 95%CI | 95% confidence interval |
| ADAM | A disintegrin and metalloprotease |
| ADC | Antibody–drug conjugate |
| aHR | Adjusted hazard ratio |
| ASC | Adipose-derived stem cell |
| ATM | Ataxia-telangiectasia mutated |
| BC | Breast cancer |
| BCSC | Breast cancer stem-like cells |
| BiTE | Bispecific T-cell engager |
| CAR | Chimeric antigen receptor |
| CBS | Cystathionine β-synthase |
| CIK | Cytokine-induced killer |
| CSE | Cystathionine γ-lyase |
| ctDNA | Circulating tumor DNA |
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 |
| DLTs | Dose-limiting toxicities |
| ECOG PS | European Eastern Cooperative Oncology Group performance status |
| EGFR | Epidermal growth factor receptor |
| EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 |
| EphA5 | Ephrin type-A receptor 5 |
| ER | Estrogen receptor |
| GSK-3β | Glycogen synthase kinase-3 beta |
| H2BK | H2B.K variant histone |
| H2S | Hydrogen sulfide |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hazard ratio |
| HSF1 | Heat shock factor 1 |
| IGFBP | Insulin-like growth factor binding protein |
| IHC | Immunohistochemistry |
| IL | Interleukin |
| INFγ | Interferon gamma |
| lncRNA | Long non-coding RNA |
| MCT4 | Monocarboxylate transporter-4 |
| Met | Methionine |
| MICA | Major histocompatibility complex class I-related protein A |
| MICB | Major histocompatibility complex class I-related protein B |
| miR | Micro RNA |
| MMP | Metalloprotease |
| mOS | Median overall survival |
| mPFS | Median progression-free survival |
| NK | Natural killer |
| NKG2D | Natural Killer group 2 member D receptor |
| NKG2DL | NKG2D ligand |
| nTPM | Normalized transcripts per million |
| ORR | Overall response rate |
| OS | Overall survival |
| PAM50 | Predictor analysis of microarray 50 |
| PCLP1 | Podocalyxin-like protein 1 |
| PFS | Progression-free survival |
| PD-L1 | Protein death ligand 1 |
| PI3K | Phosphoinositide 3-kinase |
| PR | Progesterone receptor |
| RFS | Relapse-free survival |
| RNA-seq | RNA sequencing |
| SCC | Senescent cancer cells |
| sMICA | Soluble MICA |
| sNKG2DL | Soluble NKG2D ligand |
| STAT3 | Signal transducer and activator of transcription 3 |
| TCGA | The Cancer Genome Atlas |
| TFGβ | Transforming growth factor beta |
| TNFα | Tumor necrosis factor alpha |
| TNBC | Triple-negative breast cancer |
| TPM | Transcripts per million |
| TRUCK | T cells redirected for antigen-unrestricted cytokine-initiated killing |
| ULBP1 | UL16 binding protein 1 |
| ULBP2 | UL16 binding protein 2 |
| ULBP3 | UL16 binding protein 3 |
| ULBP4 | UL16 binding protein 4. Also: RAET1E (Retinoic Acid Early Transcript 1E) |
| ULBP5 | UL16 binding protein 5. Also: RAET1G (Retinoic Acid Early Transcript 1G) |
| ULBP6 | UL16 binding protein 6. Also: RAET1L (Retinoic Acid Early Transcript 1L) |
| Val | Valine |
| XOR | Xanthine oxidoreductase |